SynthesisBMC pregnancy and childbirth2022

Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis.

Han Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.